These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24900914)

  • 1. Investigation of PACAP Fragments and Related Peptides in Chronic Retinal Hypoperfusion.
    Werling D; Reglodi D; Kiss P; Toth G; Szabadfi K; Tamas A; Biro Z; Atlasz T
    J Ophthalmol; 2014; 2014():563812. PubMed ID: 24900914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Protective Role of PAC1-Receptor Agonist Maxadilan in BCCAO-Induced Retinal Degeneration.
    Vaczy A; Reglodi D; Somoskeoy T; Kovacs K; Lokos E; Szabo E; Tamas A; Atlasz T
    J Mol Neurosci; 2016 Oct; 60(2):186-94. PubMed ID: 27566170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular Delivery of PACAP1-27 Protects the Retina From Ischemic Damage in Rodents.
    Werling D; Reglodi D; Banks WA; Salameh TS; Kovacs K; Kvarik T; Vaczy A; Kovacs L; Mayer F; Danyadi B; Lokos E; Tamas A; Toth G; Biro Z; Atlasz T
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6683-6691. PubMed ID: 27936470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of vasoactive intestinal peptide (VIP) in ischemic retinal degeneration.
    Szabadfi K; Danyadi B; Kiss P; Tamas A; Fabian E; Gabriel R; Reglodi D
    J Mol Neurosci; 2012 Nov; 48(3):501-7. PubMed ID: 22544514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the protective effects of PACAP with cell-specific markers in ischemia-induced retinal degeneration.
    Atlasz T; Szabadfi K; Kiss P; Tamas A; Toth G; Reglodi D; Gabriel R
    Brain Res Bull; 2010 Mar; 81(4-5):497-504. PubMed ID: 19751807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of PACAP on MAP kinases, Akt and cytokine expressions in rat retinal hypoperfusion.
    Szabo A; Danyadi B; Bognar E; Szabadfi K; Fabian E; Kiss P; Mester L; Manavalan S; Atlasz T; Gabriel R; Toth G; Tamas A; Reglodi D; Kovacs K
    Neurosci Lett; 2012 Aug; 523(2):93-8. PubMed ID: 22750211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PACAP application improves functional outcome of chronic retinal ischemic injury in rats-evidence from electroretinographic measurements.
    Danyadi B; Szabadfi K; Reglodi D; Mihalik A; Danyadi T; Kovacs Z; Batai I; Tamas A; Kiss P; Toth G; Gabriel R
    J Mol Neurosci; 2014 Nov; 54(3):293-9. PubMed ID: 24723665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide.
    Atlasz T; Werling D; Song S; Szabo E; Vaczy A; Kovari P; Tamas A; Reglodi D; Yu R
    J Mol Neurosci; 2019 Jul; 68(3):397-407. PubMed ID: 30542799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passage through the Ocular Barriers and Beneficial Effects in Retinal Ischemia of Topical Application of PACAP1-38 in Rodents.
    Werling D; Banks WA; Salameh TS; Kvarik T; Kovacs LA; Vaczy A; Szabo E; Mayer F; Varga R; Tamas A; Toth G; Biro Z; Atlasz T; Reglodi D
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects.
    Atlasz T; Szabadfi K; Kiss P; Racz B; Gallyas F; Tamas A; Gaal V; Marton Z; Gabriel R; Reglodi D
    Ann N Y Acad Sci; 2010 Jul; 1200():128-39. PubMed ID: 20633141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo.
    Szabadfi K; Atlasz T; Kiss P; Danyadi B; Tamas A; Helyes Z; Hashimoto H; Shintani N; Baba A; Toth G; Gabriel R; Reglodi D
    Neurotox Res; 2012 Jan; 21(1):41-8. PubMed ID: 21717232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel neuroprotective strategies in ischemic retinal lesions.
    Szabadfi K; Mester L; Reglodi D; Kiss P; Babai N; Racz B; Kovacs K; Szabo A; Tamas A; Gabriel R; Atlasz T
    Int J Mol Sci; 2010 Feb; 11(2):544-561. PubMed ID: 20386654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing Pathway.
    Szabadfi K; Reglodi D; Szabo A; Szalontai B; Valasek A; Setalo G; Kiss P; Tamas A; Wilhelm M; Gabriel R
    Neurotox Res; 2016 Apr; 29(3):432-46. PubMed ID: 26739825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary adenylate cyclase activating polypeptide is protective in bilateral carotid occlusion-induced retinal lesion in rats.
    Atlasz T; Babai N; Kiss P; Reglodi D; Tamás A; Szabadfi K; Tóth G; Hegyi O; Lubics A; Gábriel R
    Gen Comp Endocrinol; 2007; 153(1-3):108-14. PubMed ID: 17289046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PACAP-mediated neuroprotection of neurochemically identified cell types in MSG-induced retinal degeneration.
    Atlasz T; Szabadfi K; Kiss P; Babai N; Koszegi Z; Tamas A; Reglodi D; Gabriel R
    J Mol Neurosci; 2008 Nov; 36(1-3):97-104. PubMed ID: 18418735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pituitary adenylate cyclase activating polypeptide in retinal degeneration induced by monosodium-glutamate.
    Tamás A; Gábriel R; Rácz B; Dénes V; Kiss P; Lubics A; Lengvári I; Reglodi D
    Neurosci Lett; 2004 Nov; 372(1-2):110-3. PubMed ID: 15531098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic bilateral common carotid artery occlusion: a model for ocular ischemic syndrome in the rat.
    Lavinsky D; Arterni NS; Achaval M; Netto CA
    Graefes Arch Clin Exp Ophthalmol; 2006 Feb; 244(2):199-204. PubMed ID: 15983810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preconditioning with volatile anaesthetic sevoflurane in ischemic retinal lesion in rats.
    Szabadfi K; Danyadi B; Kiss P; Manavalan S; Gabriel R; Reglodi D; Tamas A; Trasy D; Batai I
    J Mol Histol; 2012 Oct; 43(5):565-9. PubMed ID: 22684245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PACAP Is Protective in a Rat Model of Retinopathy of Prematurity.
    Kvarik T; Mammel B; Reglodi D; Kovacs K; Werling D; Bede B; Vaczy A; Fabian E; Toth G; Kiss P; Tamas A; Ertl T; Gyarmati J; Atlasz T
    J Mol Neurosci; 2016 Oct; 60(2):179-85. PubMed ID: 27561927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative neuroprotective effects of preischemic PACAP and VIP administration in permanent occlusion of the middle cerebral artery in rats.
    Tamás A; Reglõdi D; Szántó Z; Borsiczky B; Németh J; Lengvári I
    Neuro Endocrinol Lett; 2002 Jun; 23(3):249-54. PubMed ID: 12080287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.